Bisphosponate Fractures: Elusive but Dangerous
|
|
- Vanessa Henderson
- 5 years ago
- Views:
Transcription
1 Krista Weiss, 2014 Gillian Lieberman, MD October 25, 2013 Bisphosponate Fractures: Elusive but Dangerous Krista Weiss, Tufts Medical School Year IV Gillian Lieberman, MD
2 Presentation Outline Our Patient: Clinical Presentation, Radiographs, and Diagnosis Bisphosphonate Fractures: Overview, Clinical Effects, Radiographic Findings Companion Patients Bisphosphonate Fractures: Treatment Summary 2
3 Presentation Outline Our Patient: Clinical Presentation, Radiographs, and Diagnosis Bisphosphonate Fractures: Overview, Clinical Effects, Radiographic Findings Companion Patients Bisphosphonate Fractures: Treatment Summary 3
4 Our Patient: Clinical Presentation History: 67 Asian female p/w acute left thigh pain s/p mechanical fall. Further endorses 2 mos of thigh discomfort. PMHx: HTN, HLD, osteoporosis, osteoarthritis Medications: Lisinopril, Simvastatin, Alendronate SHx: Lives in greater Boston area, works as secretary 2
5 Now that we have reviewed the patient s history, let s consider the differential diagnosis of acute thigh pain 5
6 DDx: Acute Thigh Pain Fracture 2/2 osteoporosis, Vit D def, trauma, etc Ligament sprain, muscle strain DVT, thrombophlebitis Claudication Sciatica, neuropathic pain Infection abscess, osteomyelitis 6
7 In order to narrow the differential diagnosis, plain films were obtained. Let s first review the patient s previous plain films from 2 months prior to establish a comparison 7
8 Our Patient: Plain Film Findings Unlabeled Two months prior to acute thigh pain, pt had hip plain films for nagging leg pain Pause to review the film. Continue to view the finding Courtesy of Robert Ward, MD, Tufts Medical Center 8
9 Our Patient: Previous Plain Film Incomplete Atypical Fracture Two months prior to acute thigh pain, pt had hip plain films for nagging hip pain Finding: incomplete atypical fracture patient lost health insurance and was lost to follow up Courtesy of Robert Ward, MD, Tufts Medical Center 9
10 Now that we have reviewed the previous comparison film, let s review the current plain films 10
11 Our Patient: Current Plain Film Incomplete Atypical Fracture Today s film shows marked interval change Impression: acute left subtrochanteric fracture BIDMC PACS 11
12 Our Patient: Biopsy & Diagnosis Patient underwent surgical fixation of fracture with biopsy of fracture site Pathology: depressed bone formation, absence of double-tetracycline labeling Double-tetracycline labeling is used to assess bone growth if absent, bone growth is also absent or poor Diagnosis: Bisphosphonate fracture 12
13 Presentation Outline Our Patient: Clinical Presentation, Radiographs, and Diagnosis Bisphosphonate Fractures: Overview, Clinical Effects, Radiographic Findings Companion Patients Bisphosphonate Fractures: Treatment Summary 13
14 Bisphosphonates: MOA Examples: alendronate, zoledronic acid, pamidronate, risedronate, ibandronate MOA: Bisphosphonates (alendronate, zoledronic acid, pamidronate, risedronate, ibandronate) INHIBITED farnesyl pyrophosphate synthetase (cholesterol synthesis enzyme) Osteoclast apoptosis Bone turnover SUPPRESSED suppression of bone turnover increased bone mass w/ maintenance of microarchitecture improved structural biomechanical properties (Saleh et al 2013) 14
15 Bisphosphonates: Clinical Effects Clinical Effect: decrease vertebral & non-vertebral fractures w/ use < 5yrs however, recent controversy about possible increase in atypical fractures (Lo et al 2012) Typical High-energy trauma Comminuted Spiral configuration Atypical Low-energy trauma Non-comminuted Transverse or short oblique fx pattern 15
16 16 Atypical Femoral Fractures: Major & Minor Features From Saleh A, Hegde VV, Potty AG, Lane JM. Bisphosphonate therapy and atypical fractures. Orthop Clin N Am 2013;44:
17 Bisphosphonate Fractures: Clinical Presentation & Epidemiology Clinical Presentation: prodromal thigh pain acute thigh pain Epidemiology: Recent studies estimate rates of atypical femoral fractures at ~4-5 per 100,000 person-yrs & at ~55 per 100,000 person-yrs among pts taking bisphosphonates (Saleh et al 2013) Etiology: Bisphosphonates (alendronate, zoledronic acid, pamidronate, risedronate, ibandronate) INHIBITED farnesyl pyrophosphate synthetase (cholesterol synthesis enzyme) Osteoclast apoptosis Bone turnover SUPPRESSED Altered microdamage physiology, mineralization, & collagen cross-linking bone errors unable to be corrected 17
18 Now that we have reviewed the effects of bisphosphonate medications on bone formation, let s reexamine our patient s plain films 18
19 Bisphosphonate Fractures: Plain Film Findings (Unlabeled) Pause to review film. Continue to view findings. BIDMC PACS 19
20 Bisphosphonate Fractures: Plain Film Findings (part 1) Plain Film/CT: periosteal stress rxn simple transverse or oblique, noncomminuted fracture Callus rxn localized lateral cortical hypertrophy Medial spike Fracture angle (Schilcher et al 2012) BIDMC PACS 20
21 Bisphosphonate Fractures: Plain Film Findings (part 2) Plain Film/CT: periosteal stress rxn simple transverse or oblique, noncomminuted fracture Callus rxn localized lateral cortical hypertrophy Medial spike Fracture angle (Schilcher et al 2012) BIDMC PACS 21
22 Bisphosphonate Fractures: Findings on Other Modalities CT: black fracture line MRI: lateral cortical thickening or irregularity localized bone marrow edema visible fracture line Bone scan: focal lateral cortical increased activity Ward et al
23 Presentation Outline Our Patient: Clinical Presentation, Radiographs, and Diagnosis Bisphosphonate Fractures: Overview, Clinical Effects, Radiographic Findings Companion Patients Bisphosphonate Fractures: Treatment Summary 23
24 Now that we have reviewed the key radiologic findings of bisphosphonate fractures, let s continue to view these findings in companion patients 24
25 Companion Pt #1: Plain Film Findings Incomplete Fx Radiolucent fx line Atypical fx w/ periosteal rxn From Saleh A, Hegde VV, Potty AG, Lane JM. Bisphosphonate therapy and atypical fractures. Orthop Clin N Am 2013;44:
26 Companion Pt #1: MRI Findings Incomplete Fx Coronal MRI T1 Coronal MRI T2 Fx line extending through cortex Bone marrow edema From Saleh A, Hegde VV, Potty AG, Lane JM. Bisphosphonate therapy and atypical fractures. Orthop Clin N Am 2013;44:
27 Companion Pt #1: Plain Film Findings Complete Fx Callus rxn localized lateral cortical hypertrophy Generalized cortical thickening Fracture angle From Saleh A, Hegde VV, Potty AG, Lane JM. Bisphosphonate therapy and atypical fractures. Orthop Clin N Am 2013;44:
28 Companion Pt #2: Plain Film Bilateral Hips Spontaneous subtrochanteric fx of left femur, s/p intramedullary fixation From Ing-Lorenzini K, Desmeules J, Plachta O, Suva D, Dayer P, Peter R. Low-energy femoral fractures associated with the long-term use of bisphosphonates. Drug Safety 2009;32(9):
29 Companion Pt #2: Plain Film Right Femur Subsequent pain in right thigh PPx intramedullary nailing & biopsy of cortex (see arrow) fx filled w/ blood, no cellular rxn or osteoclastic activity From Ing-Lorenzini K, Desmeules J, Plachta O, Suva D, Dayer P, Peter R. Low-energy femoral fractures associated with the longterm use of bisphosphonates. Drug Safety 2009;32(9):
30 Presentation Outline Our Patient: Clinical Presentation, Radiographs, and Diagnosis Bisphosphonate Fractures: Overview, Clinical Effects, Radiographic Findings Companion Patients Bisphosphonate Fractures: Treatment Summary 30
31 Bisphosphonate Fractures: Treatment If fracture has not yet occurred, discontinue bisphosphonates & pin femur prophylactically If fracture has occurred (our patient): Stabilize fracture may need surgical management Discontinue bisphosphonates to avoid delayed bone remodeling Ca & Vit D supplementation Teriparatide (recombinant PTH): improves bone turnover & microarchitecture, enhances fx healing Assess contralateral femur (Saleh et al 2013) research/01-projects/61- femur/sketch_nailing.png 31
32 Our Patient: Follow Up Our patient went to the operating room for internal fixation of her left femoral fracture Further, her Alendronate was discontinued and she was prescribed Ca, Vit. D & Teriparatide Importantly, her right femur was closely examined on x-ray for signs of contralateral impending fracture! 32
33 Presentation Outline Our Patient: Clinical Presentation, Radiographs, and Diagnosis Bisphosphonate Fractures: Overview, Clinical Effects, Radiographic Findings Companion Patients Bisphosphonate Fractures: Treatment Summary 33
34 Summary Bisphosphonates are associated with atypical femur fractures Highly specific radiographic features can identify at-risk pts before complete atypical fractures occur Monitor patients on bisphosphonates for symptoms of chronic thigh pain or subtle abnormalities on plain film or other imaging Future studies may help to elucidate further prevention of femoral fractures and their associated morbidity and mortality 34
35 Acknowledgments Dr. Robert Ward Dr. Jim Wu Dr. Gillian Lieberman Claire Odom Dr. Omer Awan Dr. Justin Kung 35
36 References Grissom LE, Harcke HT. Radiographic features of bisphosphonate therapy in pediatric patients. Pediatric Radiol 2003;33: Ing-Lorenzini K, Desmeules J, Plachta O, Suva D, Dayer P, Peter R. Low-energy femoral fractures associated with the long-term use of bisphosphonates. Drug Safety 2009;32(9): Lo JC, Huang SY, Lee GA, Khandewal S, Provus J, Ettinger B, Gonzalez JR, Hui RL, Grimsrud CD. Clinical correlates of atypical femoral fracture. Bone 2012;51: Saleh A, Hegde VV, Potty AG, Lane JM. Bisphosphonate therapy and atypical fractures. Orthop Clin N Am 2013;44: Schilcher J, Koeppen V, Ranstan J, Skripitz R, Michaelson K, Aspenburg P. Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls. Bone 2013;52: Ward WG, Carter CJ, Wilson SC, Emory CL. Femoral stress fractures associated with long-term bisphosphonate treatment. Clin Orthop Relat Res 2012;470:
Atypical Femoral Fracture: 2015 Position Statement of the Korean Society for Bone and Mineral Research
J Bone Metab 2015;22:87-91 http://dx.doi.org/10.11005/jbm.2015.22.3.87 pissn 2287-6375 eissn 2287-7029 Review Article Atypical Femoral Fracture: 2015 Position Statement of the Korean Society for Bone and
More informationAtypical Femoral Fractures With Long Term Bisphosphonates Use
Atypical Femoral Fractures With Long Term Bisphosphonates Use There has been an increase in the number of atypical femoral fractures in pa4ents on long term bisphosphonate therapy (e.g Fosamax) Accordingly
More information1/28/2017. Orthopedic Implications Of Osteoporosis Introduction. Orthopedic Implications Of Osteoporosis Introduction
The Orthopedic Implications Of Prolonged In Osteoporosis Donald A. Wiss MD Director Of Orthopedic Trauma Cedars Sinai Medical Center Orthopedic Implications Of Osteoporosis Introduction Osteoporosis Most
More informationFemoral Shaft Cortical Pathology associated with longterm Alendronate Therapy: A New Classification
Malaysian Orthopaedic Journal 2013 Vol 7 No 3 Doi:http://dx.doi.org/10.5704/MOJ.1307.008 MK Kwan, et al Femoral Shaft Cortical Pathology associated with longterm Alendronate Therapy: A New Classification
More informationAtypical Femoral Fractures Insights and Enigmas
Atypical Femoral Fractures Insights and Enigmas Madhu Mehta, M.D. Clinical Asst. Prof. of Medicine Department of Immunology/Rheumatology The Ohio State University Abreviations used TFF- Typical femoral
More informationFrequency of Incomplete Atypical Femoral Fractures in Asymptomatic Patients on Long- Term Bisphosphonate Therapy
Musculoskeletal Imaging Original Research La Rocca Vieira et al. Femoral Fractures in Asymptomatic Patients Musculoskeletal Imaging Original Research Renata La Rocca Vieira 1 Zehava Sadka Rosenberg 1 Mary
More informationTREATMENT OF OSTEOPOROSIS HOLIDAYS OR NO HOLIDAYS? Nelson B. Watts, MD OSTEOPOROSIS AND BONE HEALTH SERVICES CINCINNATI, OHIO
TREATMENT OF OSTEOPOROSIS HOLIDAYS OR NO HOLIDAYS? Nelson B. Watts, MD OSTEOPOROSIS AND BONE HEALTH SERVICES CINCINNATI, OHIO DISCLOSURES Honoraria: Amgen, Merck, Shire Consulting : AbbVie, Amgen, Merck,
More informationOTA Highlight Paper. Surgical Treatment Improves Clinical and Functional ACCEPTED. Outcomes for Patients who Sustain Incomplete
Journal of Orthopaedic Trauma Publish Ahead of Print DOI: 10.1097/BOT.0b013e31827240ae OTA Highlight Paper Surgical Treatment Improves Clinical and Functional Outcomes for Patients who Sustain Incomplete
More informationUsing GE Lunar DXA to Quantify, Visualize, and Trend Incipient Atypical Femoral Fractures
Using GE Lunar DXA to Quantify, Visualize, and Trend Incipient Atypical Femoral Fractures The management of osteoporosis underwent a paradigm shift in 1995 with the approval of the first bisphosphonate,
More informationBilateral Insufficiency Fracture of Medial Subtrochanteric Area of the Femur: A Case Report
CASE REPORT Hip Pelvis 25(3): 232-236, 2013 http://dx.doi.org/10.5371/hp.2013.25.3.232 Print ISSN 2287-3260 Online ISSN 2287-3279 Bilateral Insufficiency Fracture of Medial Subtrochanteric Area of the
More informationFrom Fragile to Firm. Monika Starosta MD. Advocate Medical Group
From Fragile to Firm Monika Starosta MD Advocate Medical Group Bone Remodeling 10% remodeled each year Calcium homoeostasis Maintain Mechanical strength Replace Osteocytes Release Growth Factors Bone remodeling
More informationATYPICAL FEMORAL FRACTURES AFTER LONG-TERM BISPHOS- PHONATES THERAPY: CASE REPORT
Rev. Med. Chir. Soc. Med. Nat., Iaşi 2016 vol. 120, no. 1 INTERNAL MEDICINE - PEDIATRICS CASE REPORTS ATYPICAL FEMORAL FRACTURES AFTER LONG-TERM BISPHOS- PHONATES THERAPY: CASE REPORT Corina Găleşanu 1,3*,
More informationBisphosphonate-related bilateral atypical femoral fractures be aware and beware
Case Report Bisphosphonate-related bilateral atypical femoral fractures be aware and beware Ruben Depasquale, Claire Matthews, Victor N. Cassar-Pullicino Abstract Although bisphosphonates have a well established
More informationSubtrochanteric Femoral Fracture in a Patient on Alendronate Therapy: A Case Report
Subtrochanteric Femoral Fracture in a Patient on Alendronate Therapy: A Case Report K.C. Lakati 1, M.B.L. Lutomia 2 1 Nakuru Orthopedic Center, 2 Egerton University Medical School, Nakuru, Kenya. Correspondence
More informationDisclosures D. Black. Bisphosphonates: Background, Efficacy and Recent Controversies. Page 1. Research Funding: Novartis, Merck
Bisphosphonates: Background, Efficacy and Recent Controversies Disclosures D. Black Research Funding: Novartis, Merck Dennis M. Black, PhD Consulting: Amgen, Lilly, Zosano, Nycomed Dept. of Epidemiology
More informationClinical Analysis of Femur Shaft Insufficiency Fractures
Original Article Clinics in Orthopedic Surgery 2012;4:227-233 http://dx.doi.org/10.4055/cios.2012.4.3.227 Clinical Analysis of Femur Shaft Insufficiency Fractures Sang-Bong Ko, MD, Sang-Wook Lee, MD, Chang-Min
More informationCase Report Combined Effect of a Locking Plate and Teriparatide for Incomplete Atypical Femoral Fracture: Two Case Reports of Curved Femurs
Case Reports in Orthopedics Volume 2015, Article ID 213614, 5 pages http://dx.doi.org/10.1155/2015/213614 Case Report Combined Effect of a Locking Plate and Teriparatide for Incomplete Atypical Femoral
More informationOsteoporosis: An Overview. Carolyn J. Crandall, MD, MS
Osteoporosis: An Overview Carolyn J. Crandall, MD, MS Osteoporosis: An Overview Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA Objectives Review osteoporosis
More informationCIC Edizioni Internazionali. Atypical femur fractures. Mini-review
Mini-review Andrea Cozzi Lepri 1 Antonio Capone 2 Armando Del Prete 1 Stefano Soderi 1 Francesco Muncibì 1 Roberto Civinini 1 1 Orthopaedic Clinic, University of Florence, Florence, Italy 2 Orthopaedic
More informationSpongeBone Menopants*
SpongeBone Menopants* Adam Fershko, MD, FACP Kettering Health Network *Postmenopausal Osteoporosis Objectives O Epidemiology O Clinical significance O Pathophysiology O Screening and Diagnosis O Treatment
More informationAtypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
REVIEW JBMR Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research Elizabeth Shane,* David Burr,* Bo Abrahamsen,
More informationChealon Miller, HMS IV Gillian Lieberman, MD. November Stress Fractures. Chealon Miller, Harvard Medical School Year IV Gillian Lieberman, MD
November 2005 Stress Fractures Chealon Miller, Harvard Medical School Year IV Our Patient G.F. 29 year old female runner c/o left shin pain and swelling Evaluated at OSH with MRI showing a mass Referred
More informationFracture=Bone Attack:
Fracture=Bone Attack: Linking Hip Fractures to Osteoporosis Care Angela M. Cheung, MD, PhD, FRCPC Professor of Medicine, University of Toronto Potential Conflicts of Interests Industry Grants (to UHN)
More informationTreatments for Osteoporosis Expected Benefits, Potential Harms and Drug Holidays. Suzanne Morin MD FRCP FACP McGill University May 2014
Treatments for Osteoporosis Expected Benefits, Potential Harms and Drug Holidays Suzanne Morin MD FRCP FACP McGill University May 2014 Learning Objectives Overview of osteoporosis management Outline efficacy
More information4/28/2010. Fractures. Normal Bone and Normal Ossification Bone Terms. Epiphysis Epiphyseal Plate (physis) Metaphysis
Fractures Normal Bone and Normal Ossification Bone Terms Epiphysis Epiphyseal Plate (physis) Metaphysis Diaphysis 1 Fracture Classifications A. Longitudinal B. Transverse C. Oblique D. Spiral E. Incomplete
More informationAtypical Femur Fx Update. Faculty Disclosures
Atypical Femur Fx Update Rick MD Faculty Disclosures Amgen Speaker Merck Speaker BioClinica Consultant. 2 The World Health Organization considers osteoporosis to be second only to cardiovascular diseases
More informationEffect of Teriparatide on Healing of Atypical Femoral Fractures: A Systemic Review
J Bone Metab 2015;22:183-189 http://dx.doi.org/10.11005/jbm.2015.22.4.183 pissn 2287-6375 eissn 2287-7029 Review Article Effect of Teriparatide on Healing of Atypical Femoral Fractures: A Systemic Review
More informationDownload slides:
Download slides: https://www.tinyurl.com/m67zcnn https://tinyurl.com/kazchbn OSTEOPOROSIS REVIEW AND UPDATE Boca Raton Regional Hospital Internal Medicine Conference 2017 Benjamin Wang, M.D., FRCPC Division
More informationPathogenesis, Management and Prevention of Atypical Femoral Fractures
J Bone Metab 2015;22:1-8 http://dx.doi.org/10.11005/jbm.2015.22.1.1 pissn 2287-6375 eissn 2287-7029 Review Article Pathogenesis, Management and Prevention of Atypical Femoral Fractures Gun-Il Im, Seung-Hyo
More informationAssessment and Treatment of Osteoporosis Professor T.Masud
Assessment and Treatment of Osteoporosis Professor T.Masud Nottingham University Hospitals NHS Trust University of Nottingham University of Derby University of Southern Denmark What is Osteoporosis? Osteoporosis
More informationAmong the most important concerns regarding the
140 Osteoporosis An Update Stephen Honig, M.D., M.Sc., and Gregory Chang, M.D. Abstract The past year has been a dynamic one for clinicians and researchers with an interest in osteoporosis. This update
More informationDrug Intervals (Holidays) with Oral Bisphosphonates
Drug Intervals (Holidays) with Oral Bisphosphonates Rizwan Rajak Consultant Rheumatologist & Lead for Osteoporosis GP Postgraduate Meeting April 2018 Contents Case presentation Pathway for Bisphosphonate
More informationUpdates in Osteoporosis. I have no conflicts of interest. What Would You Do? Mrs. C. What s New in Osteoporosis. Page 1
Updates in Osteoporosis Jeffrey A. Tice, MD Associate Professor of Medicine Division of General Internal Medicine, University of California, San Francisco I have no conflicts of interest What s New in
More informationCase report. subsequent uptake by osteoclasts result in sustained inhibition of bone resorption, even after cessation of
HORMONES 2013, 12(4):591-597 Case report Sequential treatment with teriparatide and strontium ranelate in a postmenopausal woman with atypical femoral fractures after long-term bisphosphonate administration
More informationCurrent and Emerging Strategies for Osteoporosis
Current and Emerging Strategies for Osteoporosis I have nothing to disclose. Anne Schafer, MD Assistant Professor of Medicine Division of Endocrinology & Metabolism December 12, 2014 Outline Osteoporosis
More informationCIC Edizioni Internazionali
Knowledge gap among general practitioners, endocrinologists and orthopedic surgeons regarding atypical lesions and fractures of the femur due to long-term use of bisphosphonates Eran Keltz 1 Igor Doronov
More informationRELEVANT DISCLOSURES OR CONFLICTS OF INTEREST PATHOPHYSIOLOGY -MECHANICAL STRESS FRACTURES OF THE LOWER EXTREMITIES
RELEVANT DISCLOSURES OR CONFLICTS OF INTEREST STRESS FRACTURES OF THE LOWER EXTREMITIES NONE Mark A Foreman M.D. Assistant Professor, UTHSCSA General Orthopedics and Trauma WHAT IS A STRESS FRACTURE? A
More informationCase Report Long-Term Alendronate Use Not without Consequences?
International Rheumatology Volume 2009, Article ID 253432, 6 pages doi:10.1155/2009/253432 Case Report ong-term Alendronate Use Not without Consequences? M. P. Somford, 1 G. F. A. E. Geurts, 2 J. W. A.
More informationBalancing the Risks and Benefits of Osteoporosis Treatment: part I: 3 to 5 years treatment
Balancing the Risks and Benefits of Osteoporosis Treatment: part I: 3 to 5 years treatment Dennis M. Black, PhD Department of Epidemiology and Biostatistics, UCSF Financial Disclosures (past 3 years) -Consulting
More informationAnabolic Therapy With Teriparatide Indications Beyond Osteoporosis
Anabolic Therapy With Teriparatide Indications Beyond Osteoporosis Andreas Panagopoulos MD, PhD Upper Limb & Sports Medicine Orthopaedic Surgeon Assistant Professor, University of Patras Outline Teriparatide
More information11/4/2018 SUBTLETIES OF LOWER EXTREMITY TRAUMA IMAGING SPEAKER DISCLOSURES
SUBTLETIES OF LOWER EXTREMITY TRAUMA IMAGING Charles S. Resnik, M.D. Professor of Radiology University of Maryland School of Medicine Upon completion of this presentation, participants will be better able
More informationThe Bare Bones of Osteoporosis. Wendy Rosenthal, PharmD
The Bare Bones of Osteoporosis Wendy Rosenthal, PharmD Definition A systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase
More informationPage 1. Diagnosis and Treatment of Osteoporosis: What s New and Controversial in 2018? What s New in Osteoporosis
Diagnosis and Treatment of Osteoporosis: What s New and Controversial in 2018? Douglas C. Bauer, MD Professor of Medicine and Epidemiology & Biostatistics University of California, San Francisco What s
More informationDiagnosis and Treatment of Osteoporosis: What s New and Controversial in ? What s New in Osteoporosis
Diagnosis and Treatment of Osteoporosis: What s New and Controversial in 2018-19? What s New in Osteoporosis The crisis in treatment and compliance Douglas C. Bauer, MD Professor of Medicine and Epidemiology
More informationAACE/ACE Osteoporosis Treatment Decision Tool
AACE/ACE Osteoporosis Treatment Decision Tool What is Osteoporosis? OSTEOPOROSIS is defined as reduced bone strength leading to an increased risk of fracture. Osteoporosis, or porous bones, occurs when
More informationRefracture Prevention The Role of Primary Care
MonashHealth Refracture Prevention The Role of Primary Care Professor Peter R Ebeling AO MBBS MD FRACP Head, Department of Medicine School for Clinical Sciences Monash Health Translation Precinct Monash
More informationManagement of postmenopausal osteoporosis
Management of postmenopausal osteoporosis Yeap SS, Hew FL, Chan SP, on behalf of the Malaysian Osteoporosis Society Committee Working Group for the Clinical Guidance on the Management of Osteoporosis,
More informationEthan M. Braunstein, M.D. 1, Steven A. Goldstein, Ph.D. 2, Janet Ku, M.S. 2, Patrick Smith, M.D. 2, and Larry S. Matthews, M.D. 2
Skeletal Radiol (1986) 15:27-31 Skeletal Radiology Computed tomography and plain radiography in experimental fracture healing Ethan M. Braunstein, M.D. 1, Steven A. Goldstein, Ph.D. 2, Janet Ku, M.S. 2,
More informationCase Report Total Hip Arthroplasty after Treatment of an Atypical Subtrochanteric Femoral Fracture in a Patient with Pycnodysostosis
Volume 2015, Article ID 731910, 4 pages http://dx.doi.org/10.1155/2015/731910 Case Report Total Hip Arthroplasty after Treatment of an Atypical Subtrochanteric Femoral Fracture in a Patient with Pycnodysostosis
More informationPage 1. New Developments in Osteoporosis. What s New in Osteoporosis
New Developments in Osteoporosis Eliseo J. Pérez-Stable MD Professor of Medicine Division of General Internal Medicine Department of Medicine July 4, 2013 Declaration of full disclosure: No conflict of
More informationOutline. Switching treatment. Evidence from randomized trials. The effects of switching 7/8/2016. When and for whom? Steven Cummings, MD
Outline Switching treatment When and for whom? Steven Cummings, MD Focus on switching from alendronate or risedronate Evidence about the effects of switching on BMD Purposes of switching Symptoms Poor
More informationPOSITION PAPER. R. Rizzoli & K. Åkesson & M. Bouxsein & J. A. Kanis & N. Napoli & S. Papapoulos & J.-Y. Reginster & C. Cooper
Osteoporos Int (2011) 22:373 390 DOI 10.1007/s00198-010-1453-5 POSITION PAPER Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects
More informationHow to treat osteoporosis With what and for how long?
How to treat osteoporosis With what and for how long? Professor Neil Gittoes Consultant Endocrinologist & Honorary Professor Where will we be going? Drug therapies Current Indications Contraindications/unmet
More informationMonitoring Osteoporosis Therapy
Monitoring Osteoporosis Therapy SUZANNE MORIN DEPT OF MEDICINE, DIVISION OF GENERAL INTERNAL MEDICINE, MUHC CENTRE FOR OUTCOMES RESEARCH AND EVALUATION, RI MUHC November 2017 Conflict of Interest Disclosures
More informationPage 1. Updates in Osteoporosis. I have no conflicts of interest. What is osteoporosis? What s New in Osteoporosis
Updates in Osteoporosis Jeffrey A. Tice, MD Professor of Medicine Division of General Internal Medicine, University of California, San Francisco I have no conflicts of interest What s New in Osteoporosis
More informationUpdates in Osteoporosis
Updates in Osteoporosis Jeffrey A. Tice, MD Associate Professor of Medicine Division of General Internal Medicine, University of California, San Francisco I have no conflicts of interest What s New in
More informationTherapeutic Updates in the Prevention and Treatment of Osteoporosis
Therapeutic Updates in the Prevention and Treatment of Osteoporosis 2013 Fall Managed Care Forum Las Vegas November 15, 2013 Steven T Harris MD FACP Clinical Professor of Medicine University of California,
More informationFRAX assessment. The patient. The patient. Which drug? UK NOGG Guidance 3/22/17. Safety issues with osteoporosis treatments
The patient Safety issues with osteoporosis treatments 78 year-old lady, retired dentist, active. Family history of osteoporosis (mother, younger sister). Humerus fracture 3 months ago. Type 2 diabetes
More informationOverview. Bone Biology Osteoporosis Osteomalacia Paget s Disease Cases. People Centred Positive Compassion Excellence
Overview Osteoporosis and Metabolic Bone Disease Dr Chandini Rao Consultant Rheumatologist Bone Biology Osteoporosis Osteomalacia Paget s Disease Cases Bone Biology Osteoporosis Increased bone remodelling
More informationBisphosphonate Use and Atypical Fractures of the Femoral Shaft
T h e n e w e ngl a nd j o u r na l o f m e dic i n e original article Bisphosphonate Use and Atypical Fractures of the Femoral Shaft Jörg Schilcher, M.D., Karl Michaëlsson, M.D., Ph.D., and Per Aspenberg,
More informationDrugs Approved for Prevention and Treatment of Postmenopausal Osteoporosis
Other Treatments of Osteoporosis- Who Should Get Bisphosphonates David Slovik, M.D. Endocrine Unit Newton-Wellesley Hospital Massachusetts General Hospital Harvard Medical School Massachusetts Medical
More informationCASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS
4:30-5:15pm Ask the Expert: Osteoporosis SPEAKERS Silvina Levis, MD OSTEOPOROSIS - FACTS 1:3 older women and 1:5 older men will have a fragility fracture after age 50 After 3 years of treatment, depending
More informationPhyseal Fractures and Growth Arrest
Physeal Fractures and Growth Arrest Raymond W. Liu, M.D. Victor M. Goldberg Master Clinician-Scientist in Orthopaedics Rainbow Babies and Children s Hospital Case Western Reserve University Outline General
More informationOsteoporosis: How to Manage Long- Term Use of Bisphosphonates AKA Now What? David E Feinstein, DO, CCD November 15 th, 2017
Osteoporosis: How to Manage Long- Term Use of Bisphosphonates AKA Now What? David E Feinstein, DO, CCD November 15 th, 2017 Introduction A fracture due to OP occurs every 3 seconds around the world. 1
More informationClinical Specialist Statement Template
Clinical Specialist Statement Template Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can
More informationOsteoporosis. Overview
v2 Osteoporosis Overview Osteoporosis is defined as compromised bone strength that increases risk of fracture (NIH Consensus Conference, 2000). Bone strength is characterized by bone mineral density (BMD)
More informationOsteoporosis: current treatment and future prospects. Juliet Compston Professor Emeritus of Bone Medicine Cambridge Biomedical Campus
Osteoporosis: current treatment and future prospects Juliet Compston Professor Emeritus of Bone Medicine Cambridge Biomedical Campus Disclosures Consultancy and speaking fees for Gilead, related to development
More information5/31/2018. Ipsilateral Femoral Neck And Shaft Fractures. Ipsilateral Neck-Shaft Fractures Introduction. Ipsilateral Neck-Shaft Fractures Introduction
Ipsilateral Femoral Neck And Shaft Fractures Exchange Nailing For Non- Union Donald Wiss MD Cedars-Sinai Medical Center Los Angeles, California Introduction Uncommon Injury Invariably High Energy Trauma
More informationOne Antiresorptive Too Many A Case Report and Clinical Opinion
International Journal of Medical and Pharmaceutical Case Reports 8(3): 1-6, 2016; Article no.ijmpcr.31352 ISSN: 2394-109X, NLM ID: 101648033 SCIENCEDOMAIN international www.sciencedomain.org One Antiresorptive
More informationAlbert Leung, HMS III Gillian Lieberman, M.D. BIDMC Radiology Clerkship February 22, 2010
Albert Leung, HMS III Gillian Lieberman, M.D. BIDMC Radiology Clerkship February 22, 2010 Overview Index Patient Periosteal Reactions Differential Diagnosis Principles of Osteoid Osteomas Bone Anatomy
More informationBasic Radiographic Principles Part II
Basic Radiographic Principles Part II Kristopher Avant, D.O. October 19 th, 2016 I have no disclosures relevant to the material presented in this discussion. Good Stuff!!! 1 Really? Really! Musculoskeletal
More informationOsteoporosis Update. Case 2. Case 1: Monday morning, 8:15
Osteoporosis Update Laura E. Ryan, MD Assistant Director for Special Programs Center for Women s Health Clinical Assistant Professor of Medicine Division of Endocrinology, Diabetes and Metabolism The Ohio
More informationCIC Edizioni Internazionali
Naoki Kondo Takuya Yoda Junichi Fujisawa Katsumitsu Arai Mayumi Sakuma Hiroshi Ninomiya Hiroshige Sano Naoto Endo Division of Orthopaedic Surgery, Niigata University Graduate School of Medical and Dental
More informationOsteoporosis update. Dr. Claire Vandevelde Consultant Rheumatologist, LTHT
Osteoporosis update Dr. Claire Vandevelde Consultant Rheumatologist, LTHT Outline Background BMD Tools for assessing fracture risk Case study Denosumab Treatment breaks BMD BMD predicts fracture risk but
More informationMedicine and the Current Correlation Between Fosamax and Fractures
Medicine and the Current Correlation Between Fosamax and Fractures American Association for Justice Fosamax Telseminar June 22, 2011 2:00 3:30 pm EDT By: William B. Curtis Michael S. Wilson Curtis Law
More informationA comparative study of less invasive stabilization system and titanium elastic nailing for subtrochanteric femur fractures in older children
Acta Orthop. Belg., 2015, 81, 123-130 ORIGINAL STUDY A comparative study of less invasive stabilization system and titanium elastic nailing for subtrochanteric femur fractures in older children Liao-Jun
More informationLearning Objectives. Controversies in Osteoporosis Prevention and Management. Definition. Presenter Disclosure Information.
4 4:45 pm Controversies in Osteoporosis Prevention and Management SPEAKER Carolyn Crandall, MD, MS Presenter Disclosure Information The following relationships exist related to this presentation: Carolyn
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 21 July 2010
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 21 July 2010 Review of the dossier of the medicinal product included on the list of reimbursable medicines for a period
More informationWhat is Osteoporosis?
What is Osteoporosis? 2000 NIH Definition A skeletal disorder characterized by compromised bone strength predisposing a person to an increased risk of fracture. Bone strength reflects the integration of
More information9/9/2015 OSTEOPOROSIS WHAT S NEW AND ON THE HORIZON IN SCREENING, DRUG HOLIDAYS, SUPPLEMENTS, CONSERVATIVE THERAPY DISCLOSURES
OSTEOPOROSIS WHAT S NEW AND ON THE HORIZON IN SCREENING, DRUG HOLIDAYS, SUPPLEMENTS, CONSERVATIVE THERAPY Nelson B. Watts, MD OSTEOPOROSIS AND BONE HEALTH SERVICES CINCINNATI, OHIO DISCLOSURES Stock options/holdings,
More information9/24/2015. When Can I Use a SHS? When CAN T I Use a SHS? Sliding Hip Screw. Time proven. Technically simple. Cheap. Quick
When Can I Use a SHS? Frank A. Liporace, MD Associate Professor Director of Orthopaedic Trauma Research Director of Orthopaedic Trauma Jersey City Medical Center New York University / Hospital for Joint
More informationWho cares about fractures! is more important. October 3, 2014 CSIM Workshop Brian Wirzba, MD, FRCPC, FACP Clinical Professor Grey Nuns Hospital
Isn t Osteoporosis just a T Score less than 2.5?? Who cares about fractures! is more important. Why do I need to know this? October 3, 2014 CSIM Workshop Brian Wirzba, MD, FRCPC, FACP Clinical Professor
More informationMRI XR, CT, NM. Principal Modality (2): Case Report # 2. Date accepted: 15 March 2013
Radiological Category: Musculoskeletal Principal Modality (1): Principal Modality (2): MRI XR, CT, NM Case Report # 2 Submitted by: Hannah Safia Elamir, D.O. Faculty reviewer: Naga R. Chinapuvvula, M.D.
More informationOsteoporosis Update. Greg Summers Consultant Rheumatologist
Osteoporosis Update Greg Summers Consultant Rheumatologist DEFINITION OSTEOPOROSIS is LOW BONE MASS (& micro-architectural deterioration) causing AN INCREASED RISK OF FRACTURE 23 years 82 years 23 y/o
More informationBreast Cancer and Bone Loss. One in seven women will develop breast cancer during a lifetime
Breast Cancer and Bone Loss One in seven women will develop breast cancer during a lifetime Causes of Bone Loss in Breast Cancer Patients Aromatase inhibitors Bil Oophorectomy Hypogonadism Steroids Chemotherapy
More informationPrevalence of Osteoporosis p. 262 Consequences of Osteoporosis p. 263 Risk Factors for Osteoporosis p. 264 Attainment of Peak Bone Density p.
Dedication Preface Acknowledgments Continuing Education An Introduction to Conventions in Densitometry p. 1 Densitometry as a Quantitative Measurement Technique p. 2 Accuracy and Precision p. 2 The Skeleton
More informationKristen M. Nebel, DO PENN/ LGHP Geriatrics. Temple Family Medicine Review
Kristen M. Nebel, DO PENN/ LGHP Geriatrics 10/3/17 Temple Family Medicine Review OBJECTIVES Define Revised 2017 American College of Physician Recommendations Screening, Prevention and Treatment Application
More informationPathologic Fracture of the Femur in Brown Tumor Induced in Parathyroid Carcinoma: A Case Report
CASE REPORT Hip Pelvis 28(3): 173-177, 2016 http://dx.doi.org/10.5371/hp.2016.28.3.173 Print ISSN 2287-3260 Online ISSN 2287-3279 Pathologic Fracture of the Femur in Brown Tumor Induced in Parathyroid
More informationOsteoporosis/Fracture Prevention
Osteoporosis/Fracture Prevention NATIONAL GUIDELINE SUMMARY This guideline was developed using an evidence-based methodology by the KP National Osteoporosis/Fracture Prevention Guideline Development Team
More informationBilateral Subtrochanteric Femur Fractures in a Patient with Polymyalgia Rheumatica and Ibandronate Use
Open Journal of Clinical & Medical Case Reports Volume 1 (2015) Issue 8 Abstract ISSN 2379-1039 Bilateral Subtrochanteric Femur Fractures in a Patient with Polymyalgia Rheumatica and Ibandronate Use *1
More informationDISCLOSURES SUNDEEP KHOSLA, M.D.
ADDRESSING PATIENT CONCERNS REGARDING COMPLICATIONS OF ANTIRESORPTIVE THERAPY Sundeep Khosla, M.D. Mayo Clinic, Rochester, MN DISCLOSURES SUNDEEP KHOSLA, M.D. NONE 1 OVERALL CONCLUSIONS There has been
More informationCLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION
Donald L. Renfrew, MD Radiology Associates of the Fox Valley, 333 N. Commercial Street, Suite 100, Neenah, WI 54956 12/22/2012 Radiology Quiz of the Week # 104 Page 1 CLINICAL PRESENTATION AND RADIOLOGY
More informationAtypical femoral fractures (AFFs) have recently. Scoring System for Identifying Impending Complete Fractures in Incomplete Atypical Femoral Fractures
CLINICAL RESEARCH ARTICLE Scoring System for Identifying Impending Complete Fractures in Incomplete Atypical Femoral Fractures Byung-Woo Min, 1 * Kyung-Hoi Koo, 2 * Youn-Soo Park, 3 Chang-Wug Oh, 4 Seung-Jae
More informationLearning Objectives. Controversies in Osteoporosis Prevention and Management. Etiology. Presenter Disclosure Information. Epidemiology.
12:45 1:30pm Controversies in Osteoporosis Prevention and Management SPEAKER Carolyn Crandall, MD, MS Presenter Disclosure Information The following relationships exist related to this presentation: Carolyn
More informationHip Fractures. Anatomy. Causes. Symptoms
Hip Fractures A hip fracture is a break in the upper quarter of the femur (thigh) bone. The extent of the break depends on the forces that are involved. The type of surgery used to treat a hip fracture
More informationStress Injuries in the Young Athlete 3 rd Annual Young Athlete Conference Greg Canty, MD Medical Director, Center for Sports Medicine Asst Professor
Stress Injuries in the Young Athlete 3 rd Annual Young Athlete Conference Greg Canty, MD Medical Director, Center for Sports Medicine Asst Professor of Orthopaedics & Pediatrics Disclosures Neither I,
More informationBilateral Femoral Neck Insufficiency Fractures after Use of a Long-term Anti-resorptive Drug Therapy for Osteoporosis: A Case Report
CASE REPORT Hip Pelvis 27(2): 115-119, 2015 http://dx.doi.org/10.5371/hp.2015.27.2.115 Print ISSN 2287-3260 Online ISSN 2287-3279 Bilateral Femoral Neck Insufficiency Fractures after Use of a Long-term
More informationSummary of the risk management plan by product
Summary of the risk management plan by product 1 Elements for summary tables in the EPAR 1.1 Summary table of Safety concerns Summary of safety concerns Important identified risks Important potential risks
More informationEvaluation of Pediatric Foot Pain
May 2006 Evaluation of Pediatric Foot Pain John Flibotte, Harvard Medical School Year III Our Patient AP is a 10 year old boy with chronic R foot pain 2 Anatomy of the Foot Manusov EG, et al. (1996), Part
More informationOsteoporosis. Current Trend in Osteoporosis Management for Elderly in HK- Medical Perspective. Old Definition of Osteoporosis
Current Trend in Osteoporosis Management for Elderly in HK- Medical Perspective Dr Dicky T.K. Choy Physician Jockey Club Centre for Osteoporosis Care and Control, CUHK Osteoporosis Global public health
More information